|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Risk of venous thromboembolism and stroke associated with oral |
| contraceptives. Role of congenital thrombophilias. |
| Pini M; Scoditti U; Caliumi F; Manotti C; Quintavalla R; Pattacini C; Poli T; |
| Tagliaferri A; di Iasio MG; Bernardi F |
| RECENTI PROGRESSI IN MEDICINA. 1996 Jul-Aug;87(7-8):331-7. |
| To assess the risk of thromboembolism in women using oral contraceptives (OCs), the authors identified through |
| computer search in the hospitals of the province of Parma, Italy, all women aged 15-44 who were resident in the |
| province and had a documented thromboembolic event in the years 1989-93. The number of users and nonusers of |
| OCs was estimated by the drug sale data for the province and by the demographic statistics. In cases with venous |
| thromboembolism (VT) the prevalence of concomitant deficiency of antithrombin III, protein C, protein S, and of factor |
| V gene mutation Arg506GIn was evaluated. The incidence rate of VT was 37/59,603 woman-years in users (0.62 |
| per 1000) and 13/303,954 woman-years in nonusers (0.042 per 1000), for a relative risk (RR) of 14.5 (95% confidence |
| interval: 7.8-27.1; P < 0.001); the rate of stroke per 1000 woman-years was 0.17 in users and 0.036 in nonusers (RR = |
| 4.6; 2.9-10.7; P < 0.01). A congenital thrombophilia involving the protein C anticoagulant system was documented in |
| about 25% of young women developing venous thromboembolism while on Ocs. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Risk of venous thromboembolism and stroke associated |
| with oral contraceptives. Role of congenital thrombophilias.", is(are) Pini M; Scoditti U; Caliumi F; Manotti C; |
| Quintavalla R; Pattacini C; Poli T; Tagliaferri A; di Iasio MG; Bernardi F. The source of this article is "RECENTI |
| PROGRESSI IN MEDICINA. 1996 Jul-Aug;87(7-8):331-7.". This article was published in 1996 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 2078-06. All rights reserved with PubHealth.info) PIN: 7078 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |